RxDoctor Payments Data

Miguel Garraton Martin, MD

Otolaryngology · San Juan, PRNPI 1962430801

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,503 of the $2,475 with a category attached, or 60.7%. 8 manufacturers reported payments, led by Johnson And Johnson International at 37.9% of the total.

$2,475in general payments, 2019–2025

Across 24 payments — averaging $103.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson And Johnson International$938
  • Sanofi$486
  • Medtronic$428
  • GSK$368
  • Takeda Pharmaceuticals U.S.A., Inc.$122
  • Intersect ENT, Inc.$86
  • plus $47 from 2 others

What the payments were for

  • Travel & lodging$93838%
  • Food & beverage$1,50361%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson And Johnson International3$938
Sanofi6$486
Medtronic8$428
GSK3$368
Takeda Pharmaceuticals U.S.A., Inc.1$122
Intersect ENT, Inc.1$86
Amgen1$34
Sanofi-aventis U.S. LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,475 in reported general payments places this provider in the 85th percentile of 55 otolaryngology providers in Puerto Rico.

See all otolaryngology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$40,508
Medicare patients
113
Services billed
469

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate85$1,789
Fluocinolone Acetonide Oil25$1,710
Famotidine88$530
Omeprazole83$473
Meclizine Hcl42$391
Dexamethasone33$243
Mupirocin21$200
Montelukast Sodium13$105

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →